The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites

The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the current leading blood-stage malaria vaccine candidate. PfRH5 functions as part of the pentameric PCRCR complex containing PTRAMP, CSS, PfCyRPA and PfRIPR, all of which are essential for infection of human red blood cells...

Full description

Bibliographic Details
Main Authors: Weiss, GE, Ragotte, RJ, Quinkert, D, Lias, AM, Dans, MG, Boulet, C, Looker, O, Ventura, OD, Williams, BG, Crabb, BS, Draper, SJ, Gilson, PR
Format: Journal article
Language:English
Published: Public Library of Science 2023
_version_ 1797111502033911808
author Weiss, GE
Ragotte, RJ
Quinkert, D
Lias, AM
Dans, MG
Boulet, C
Looker, O
Ventura, OD
Williams, BG
Crabb, BS
Draper, SJ
Gilson, PR
author_facet Weiss, GE
Ragotte, RJ
Quinkert, D
Lias, AM
Dans, MG
Boulet, C
Looker, O
Ventura, OD
Williams, BG
Crabb, BS
Draper, SJ
Gilson, PR
author_sort Weiss, GE
collection OXFORD
description The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the current leading blood-stage malaria vaccine candidate. PfRH5 functions as part of the pentameric PCRCR complex containing PTRAMP, CSS, PfCyRPA and PfRIPR, all of which are essential for infection of human red blood cells (RBCs). To trigger RBC invasion, PfRH5 engages with RBC protein basigin in a step termed the RH5-basigin binding stage. Although we know increasingly more about how antibodies specific for PfRH5 can block invasion, much less is known about how antibodies recognizing other members of the PCRCR complex can inhibit invasion. To address this, we performed live cell imaging using monoclonal antibodies (mAbs) which bind PfRH5 and PfCyRPA. We measured the degree and timing of the invasion inhibition, the stage at which it occurred, as well as subsequent events. We show that parasite invasion is blocked by individual mAbs, and the degree of inhibition is enhanced when combining a mAb specific for PfRH5 with one binding PfCyRPA. In addition to directly establishing the invasion-blocking capacity of the mAbs, we identified a secondary action of certain mAbs on extracellular parasites that had not yet invaded where the mAbs appeared to inactivate the parasites by triggering a developmental pathway normally only seen after successful invasion. These findings suggest that epitopes within the PfCyRPA-PfRH5 sub-complex that elicit these dual responses may be more effective immunogens than neighboring epitopes by both blocking parasites from invading and rapidly inactivating extracellular parasites. These two protective mechanisms, prevention of invasion and inactivation of uninvaded parasites, resulting from antibody to a single epitope indicate a possible route to the development of more effective vaccines.
first_indexed 2024-03-07T08:11:19Z
format Journal article
id oxford-uuid:8f929a5f-cfd9-4d7d-ab48-17b79cf7c44b
institution University of Oxford
language English
last_indexed 2024-03-07T08:11:19Z
publishDate 2023
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:8f929a5f-cfd9-4d7d-ab48-17b79cf7c44b2023-11-24T12:21:40ZThe dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoitesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8f929a5f-cfd9-4d7d-ab48-17b79cf7c44bEnglishSymplectic ElementsPublic Library of Science2023Weiss, GERagotte, RJQuinkert, DLias, AMDans, MGBoulet, CLooker, OVentura, ODWilliams, BGCrabb, BSDraper, SJGilson, PRThe Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the current leading blood-stage malaria vaccine candidate. PfRH5 functions as part of the pentameric PCRCR complex containing PTRAMP, CSS, PfCyRPA and PfRIPR, all of which are essential for infection of human red blood cells (RBCs). To trigger RBC invasion, PfRH5 engages with RBC protein basigin in a step termed the RH5-basigin binding stage. Although we know increasingly more about how antibodies specific for PfRH5 can block invasion, much less is known about how antibodies recognizing other members of the PCRCR complex can inhibit invasion. To address this, we performed live cell imaging using monoclonal antibodies (mAbs) which bind PfRH5 and PfCyRPA. We measured the degree and timing of the invasion inhibition, the stage at which it occurred, as well as subsequent events. We show that parasite invasion is blocked by individual mAbs, and the degree of inhibition is enhanced when combining a mAb specific for PfRH5 with one binding PfCyRPA. In addition to directly establishing the invasion-blocking capacity of the mAbs, we identified a secondary action of certain mAbs on extracellular parasites that had not yet invaded where the mAbs appeared to inactivate the parasites by triggering a developmental pathway normally only seen after successful invasion. These findings suggest that epitopes within the PfCyRPA-PfRH5 sub-complex that elicit these dual responses may be more effective immunogens than neighboring epitopes by both blocking parasites from invading and rapidly inactivating extracellular parasites. These two protective mechanisms, prevention of invasion and inactivation of uninvaded parasites, resulting from antibody to a single epitope indicate a possible route to the development of more effective vaccines.
spellingShingle Weiss, GE
Ragotte, RJ
Quinkert, D
Lias, AM
Dans, MG
Boulet, C
Looker, O
Ventura, OD
Williams, BG
Crabb, BS
Draper, SJ
Gilson, PR
The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
title The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
title_full The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
title_fullStr The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
title_full_unstemmed The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
title_short The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites
title_sort dual action of human antibodies specific to plasmodium falciparum pfrh5 and pfcyrpa blocking invasion and inactivating extracellular merozoites
work_keys_str_mv AT weissge thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT ragotterj thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT quinkertd thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT liasam thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT dansmg thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT bouletc thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT lookero thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT venturaod thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT williamsbg thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT crabbbs thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT drapersj thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT gilsonpr thedualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT weissge dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT ragotterj dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT quinkertd dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT liasam dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT dansmg dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT bouletc dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT lookero dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT venturaod dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT williamsbg dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT crabbbs dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT drapersj dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites
AT gilsonpr dualactionofhumanantibodiesspecifictoplasmodiumfalciparumpfrh5andpfcyrpablockinginvasionandinactivatingextracellularmerozoites